Abstract:Novel statistical methods have emerged in recent medical literature, which clinicians must understand to properly appraise and integrate evidence into their practice. Some of these key concepts include win ratios, restricted mean survival time, responder analyses, and standardized mean difference. This article offers guidance to busy clinicians on the comprehension and practical applicability of the results to patients. Win ratios provide an alternative method to analyze composite outcomes by prioritizing individual components of the composite; prioritization of the outcomes should be evidence-based, pre-specified, and patient-centered. Restricted mean survival time presents a method to analyze Kaplan–Meier curves when assumptions required for Cox proportional hazards analysis are not met. As it only considers outcomes that occur within a specific timeframe, the duration of follow-up must be appropriately defined and based on prior epidemiologic and mechanistic evidence. Researchers can analyze continuous outcomes with responder analyses, in which participants are dichotomized into "responders" or "non-responders." While clinicians and patients may more easily grasp outcomes analyzed in this way, they should be aware of the loss of information and resulting imprecision, as well as potential to manipulate data presentation. When meta-analyzing continuous outcomes, point estimates can be converted to standardized mean differences to facilitate the combination of data utilizing various outcome measures. However, clinicians may find it challenging to grasp the clinical meaningfulness of a standardized mean difference, and may benefit from converting it to well-known outcomes. By providing the background knowledge of these statistical methods, along with practical applicability, benefits, and inevitable limitations, this article aims to provide clinicians with an approach to appraise the literature and apply the results in clinical practice.

The correct application of Stata and R software in meta-analysis for survival data

Estimate Risk Difference and Number Needed to Treat in Survival Analysis.

Meta‐epidemiological Study: a Step‐by‐step Approach by Using R

Practical methods for incorporating summary time-to-event data into meta-analysis

Semi-parametric Regression Model for Survival Data: Graphical Visualization with R.

Drawing Nomograms with R: Applications to categorical outcome and survival data

Implementation of an alternative method for assessing competing risks: restricted mean time lost

The Correct Application of Survival Analysis in Follow-up Study

Parametric Regression Model for Survival Data: Weibull Regression Model As an Example

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-to-Event Outcomes Using Average Hazard with Survival Weight

Statistical Considerations for Evaluating Treatment Effect under Various Non-proportional Hazard Scenarios

HSROC Model in Meta-Analysis of Diagnostic Test and Its Solution in Stata

Targeted Estimation of Heterogeneous Treatment Effect in Observational Survival Analysis

A Nonparametric Statistical Method for Two Crossing Survival Curves

Network Meta-Analysis of Time-to-Event Endpoints with Individual Participant Data using Restricted Mean Survival Time Regression

Semiparametric Additive Modeling of the Restricted Mean Survival Time

Clinician's Approach to Advanced Statistical Methods: Win Ratios, Restricted Mean Survival Time, Responder Analyses, and Standardized Mean Differences

Strategies for power calculations in predictive biomarker studies in survival data

Smooth Transformation Models for Survival Analysis: A Tutorial Using R

A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies

Assessing treatment effects with adjusted restricted mean time lost in observational competing risks data